Search clinical trials for: Solid Tumour

Total 9642 results

Chroma Therapeutics

Completed

Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours

Solid Tumor

Netherlands, United Kingdom
Mateon Therapeutics

Completed

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Tumors

United Kingdom
The Netherlands Cancer Institute
Pfizer

Unknown

Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors

Malignant Solid Tumour

Netherlands
AstraZeneca
Royal Marsden NHS Foundation Trust

Completed

DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)

Cancer

United Kingdom
AstraZeneca

Completed

A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies

Advanced Solid Malignancies

China
AstraZeneca

Completed

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

Advanced Solid Malignancies

China
AstraZeneca

Withdrawn

Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours

Cancer | Advanced Solid Tumours | Lymphomas
AstraZeneca

Completed

AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours

Solid Tumor

Japan
AstraZeneca

Completed

Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

Advanced Solid Tumors

Denmark, Canada
Jewish General Hospital

Unknown

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Malignant Solid Tumour

Canada
Nerviano Medical Sciences

Completed

Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors

Solid Tumour

United States
AstraZeneca
KuDOS Pharmaceuticals Limited

Completed

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan

Malignant Solid Tumors

United Kingdom
AstraZeneca

Completed

Phase I Study in Patients With Solid Tumours

Neoplasms

France, United Kingdom, Netherlands, Norway
Clavis Pharma

Completed

A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour

Solid Tumors

Netherlands, Belgium
Chroma Therapeutics
Institute of Cancer Research, United Kingdom

Completed

Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours

Advanced Solid Tumors
Ethical Oncology Science

Completed

Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas

Lymphoma, Non-Hodgkin | Solid Tumors

Switzerland, Italy
Institut Claudius Regaud
Merck Sharp & Dohme LLC

Terminated

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Malignant Solid Tumour

France
AstraZeneca

Completed

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Neoplasms

Germany
AstraZeneca

Completed

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Brain Tumor | Recurrent Glioblastoma

United States, United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Clinical Studies of Gemcitabine-Oxaliplatin

Osteosarcoma | Medulloblastoma | Neuroblastoma | Central Nervous System Tumors

France
AstraZeneca

Terminated

AZD1152 in Patients With Advanced Solid Malignancies-Study 3

Solid Tumours

United Kingdom
Antisoma Research

Completed

Study of AS1411 in Advanced Solid Tumours

Advanced Solid Tumors

United States
Eisai Limited

Suspended

A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours

Cancer

Netherlands, Spain
AstraZeneca
KuDOS Pharmaceuticals Limited

Completed

Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours

Neoplasm Metastasis

United Kingdom
Aegera Therapeutics

Terminated

Study of XIAP Antisense for Advanced Cancers

Advanced Cancer

United Kingdom
YM BioSciences
CIMYM BioSciences

Completed

Phase I Study of Nimotuzumab in Solid Tumours

Advanced and/or Metastatic Solid Tumours

Canada
Maria Sklodowska-Curie National Research Institute...

Recruiting

Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours

Head and Neck Cancer

Poland
Shanghai Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Jemincare

Not yet recruiting

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

Solid Tumor, Adult
IRCCS San Raffaele

Recruiting

Maternal Well-being in the Perinatal Period

Anxiety | Loneliness | Mother-Child Relations | Perinatal Depression

Italy
The Christie NHS Foundation Trust
University of Liverpool; University of Manchester

Not yet recruiting

Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy (DyNAMIc)

Melanoma
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Virus-associated Tumour Microenvironment (VIRONMENT)

Lymphoma | Cancers of the Lung | Cancer Anal Canal
Anaveon AG
Merck Sharp & Dohme LLC

Not yet recruiting

A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)

Advanced Solid Tumor
Stanford University

Not yet recruiting

Parent-Mediated Intervention Targeting Insistence on Sameness for Autistic Children

Autism Spectrum Disorder | Autism
Yuanquan Yang

Not yet recruiting

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

Advanced Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm

United States
L & L biopharma Co., Ltd., Shanghai China
Shanghai East Hospital

Not yet recruiting

A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors (TRIGGERCD8)

Solid Tumor

China
Sichuan Baili Pharmaceutical Co., Ltd.
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Solid Tumor | Head and Neck Squamous Cell Carcinomas

China
Shikai Wu

Recruiting

Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period

Solid Tumor, Adult

China
Seagen Inc.

Not yet recruiting

A Study of SGN-MesoC2 in Advanced Solid Tumors

Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Adenocarcinoma | Ovarian Neoplasms | Mesothelioma | Other Solid Tumors
Kumho HT Inc.

Recruiting

Study of DNP002 in Patients With Solid Tumors

Advanced Solid Tumor

Korea, Republic of
Medipol University

Not yet recruiting

Self Help Plus and Post-Migration Living Difficulties Support Intervention

Psychological Distress | Mental Health | Psychological Trauma | Refugee Health

Turkey
VA Office of Research and Development

Not yet recruiting

Increasing Veterans' Social Engagement and Connectedness (CONNECTED)

Social Isolation

United States
The First Affiliated Hospital of Xiamen University

Recruiting

ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

Solid Tumor | Thyroid Cancer | Tumor | Positron-Emission Tomography

China
Sahlgrenska University Hospital, Sweden

Recruiting

Tumour Localisation With Magnetic Clip Before Neoadjuvant Chemotherapy. (MagLocal)

Breast Conserving Surgery

Sweden
GeneQuantum Healthcare (Suzhou) Co., Ltd.

Recruiting

A Study of GQ1010 in Subjects With Advanced Solid Tumors

Advanced Malignant Solid Tumors

China
Eli Lilly and Company
Loxo Oncology, Inc.

Not yet recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (NEXUS-01)

Cervical Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Renal Pelvis Cancer | Urinary Bladder Neoplasm | Recurrent...

United States
Guangzhou Medical University

Not yet recruiting

Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors

Leptomeningeal Metastasis

China
Chengdu Baiyu Pharmaceutical Co., Ltd.

Recruiting

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors

Solid Tumor, Adult

China
CytomX Therapeutics
Merck Sharp & Dohme LLC

Not yet recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

Solid Tumor, Adult

United States
Schrödinger, Inc.

Not yet recruiting

Study of SGR-3515 In Participants With Advanced Solid Tumors.

Advanced Solid Tumor

Search clinical trials for: Solid Tumour

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations